Internal Medicine · Tampa, FL
NPI
1326257262
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
12902 Magnolia Dr. Fob-1
Tampa, FL, 33612
Phone (813) 745-3050
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
265 services
Medicare patients, 2024
117
Average age 72
Drug cost, 2024
$3.5M
738 prescriptions
Company payments, 2025
$38K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Benjamin Creelan was code 99214 (office e&m - established), 116 times for 74 patients. In total Benjamin Creelan billed 265 services in 9 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-08-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 116 | 74 | $71.05 | $8,241 |
| 99214 Office E&M - Established | Office | 54 | 34 | $100.59 | $5,432 |
| 99205 Office E&M - New | Facility | 27 | 27 | $143.61 | $3,877 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 27 | 17 | $12.97 | $350 |
By year: 2022 $26K for 298 services; 2023 $23K for 247 services; 2024 $21K for 265 services.
Medicare prescription drug claims, 2024
In 2024, the drug Benjamin Creelan prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 88 prescriptions and refills. In total Benjamin Creelan wrote 738 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 88 | 88 | 12 | $1.6M |
| Ondansetron Hcl Generic | 60 | 62 | 34 | $5,208 |
| Metoclopramide Hcl Generic | 48 | 49 | 31 | $205 |
| Oxycodone Hcl Generic | 38 | 38 | 16 | $432 |
| Dexamethasone Generic | 34 | 34 | 20 | $514 |
| Lorazepam Generic | 33 | 33 | Under 11 | $99.76 |
| Lorbrena Lorlatinib | 26 | 26 | Under 11 | $557K |
| Tramadol Hcl Generic | 23 | 23 | Under 11 | $1,405 |
| Prednisone Generic | 22 | 23 | 14 | $35.38 |
| Methylprednisolone Generic | 18 | 18 | Under 11 | $75.65 |
| Folic Acid Generic | 16 | 29 | Under 11 | $90.3 |
| Eliquis Apixaban | 16 | 32 | Under 11 | $19K |
| Xalkori Crizotinib | 13 | 13 | Under 11 | $283K |
| Alprazolam Generic | 12 | 12 | Under 11 | $28.72 |
| Mekinist Trametinib Dimethyl Sulfoxide | 12 | 12 | Under 11 | $165K |
Brand drugs: 224 claims; generic drugs: 514 claims; opioid claims: 78.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Benjamin Creelan $38K ($38K in general payments such as food, travel and fees) from 9 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $20K.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 16 | $20K |
| Regeneron Pharmaceuticals, Inc. REGN | 3 | $9,134 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $2,982 |
| GlaxoSmithKline, LLC. GSK | 1 | $2,375 |
| AstraZeneca UK Limited AZN | 3 | $1,666 |
| EMD Serono, Inc. MRK.DE | 1 | $1,425 |
| Abbvie Inc. ABBV | 1 | $725 |
| Iovance Biotherapeutics, Inc. IOVA | 1 | $90.53 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $59.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.